Reviewed treatment interventions for pediatric populations involving the co
mbination of pharmacotherapy or psychotherapy or either treatment employed
alone. The literature revealed a dearth of psychotherapy and pharmacotherap
y outcome studies, with the exception of investigations of children diagnos
ed with attention-deficit hyperactivity disorder (ADHD). Issues pertaining
to design, including sample selection, treatment integrity and comparabilit
y, and placebo controls also are reviewed. A potpourri of other issues are
noted including parental attitudes toward the use of medication versus psyc
hotherapy, treatment adherence, and patient/provider relationship. For chil
dren diagnosed with ADHD, the use of stimulant medication appears to be sup
erior to psychotherapy employed alone in managing the behavior of these chi
ldren as well as their classroom functioning. Recommendations are made for
multimodal trials that examine the combined and individual use of pharmacot
herapies and psychotherapies for various developmental and psychiatric diso
rders that occur in childhood and adolescence. Future studies also need to
address the durable effects of these treatment options.